05-May-2021 - BASF SE

BASF strengthens its global production footprint for enzymes

BASF will invest at Novartis’ Kundl/Schaftenau Campus, in Austria

On April 26, 2021 BASF has agreed with Sandoz GmbH, a subsidiary of Novartis, to invest at the Kundl/Schaftenau Campus in Austria. This agreement enables BASF to further develop its production footprint for enzymes and biotechnology products. Both parties agreed not to disclose financial details of the agreement.

“This investment is a clear sign of our commitment to the enzymes and biotechnology industry. BASF will strengthen its position in the market, as the Kundl/Schaftenau Campus has 75 years of biotechnology practice and corresponding infrastructure, including deep know-how,” said Dr. Michael De Marco, Vice President Global Business Management Enzymes for BASF.

“The agreement enables us to expand our production footprint for detergent enzymes and further enhance our product portfolio and leading market position in the Home Care and I&I industry,” said Dr. Soeren Hildebrandt, Senior Vice President Home Care, I&I and Industrial Formulators Europe. “With this step we support our customers to address key market needs such as cleaning products with superior sustainability profiles and new product formats, based on innovative BASF enzyme technology.”

"Tyrol is a key location for our global production network. Our investments in Kundl and Schaftenau  reinforce our commitment to the region," says Steffen Lang, Head of Novartis Technical Operations and member of the Novartis Executive Committee. "With the further development into a Life Science Park and the settlement of BASF, an important player in the field of biotechnology, we are strengthening the competence and innovation capacity of the area."

BASF seeks also to explore the potential to grow further via deeper involvement in the Kundl/Schaftenau Campus. The start of production is planned for 2024.

Facts, background information, dossiers
  • investments
More about BASF
  • News

    White biotechnology enables carbon recycling

    Transforming the carbon contained in industrial off-gases into valuable chemicals is the aim of a partnership between LanzaTech and BASF. Now the partners have achieved a key first success: With the help of special bacteria, they have been able to produce n-octanol at laboratory scale from ... more

    BASF invests in biotechnology start-up Bota Bio

    BASF Venture Capital (BVC) has invested in Bota Biosciences, Ltd. (Bota Bio), an industrial synthetic biotech company based in Hangzhou, China. Bota Bio, founded in 2019, is developing a proprietary next-generation biotechnology platform which enables sustainable and economical production o ... more

    BASF supports search for active ingredients to combat SARS-CoV-2

    BASF is also providing support worldwide to academic research groups in their search for a suitable active ingredient to treat patients infected with the coronavirus. “We do not develop active pharmaceutical ingredients, but BASF has more than 150 years of experience in researching substanc ... more

  • Companies

    BASF Plant Science Holding GmbH

    BASF's activities in the field of plant biotechnology are consolidated in BASF Plant Science. BASF Plant Science is an internationally networked research and technology Verbund with eight research centers in Europe and North America. In addition, there are a great number of cooperative agre ... more

    BASF Pharma (Evionnaz) SA


More about Novartis